+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

B-cell Activating Factor Receptor

Catalog No Product Description CAS No. Purity Structural Formula
SBP03057 1245-00-7 Sitsirikine
SBP02859 16049-28-8 Antirhine
BP3535
L-Cystine
L-cystine is the L-enantiomer of the sulfur-containing amino acid cystine. It has a role as an EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor, a flour treatment agent, a mouse metabolite, a Saccharomyces cerevisiae metabolite and a human metabolite. It is a cystine, a non-proteinogenic L-alpha-amino acid and a L-cysteine derivative. It is a conjugate acid of a L-cystine anion. It is an enantiomer of a D-cystine. It is a tautomer of a L-cystine zwitterion. L-Cystine can improve hyperlipidemia by restoring LPL and HSL activities.L-Cystine protects against the toxicity of PQ by maintaining reduced glutathione levels in the cells. Co-administration of l-cystine and l-theanine before vaccination may enhance the immune response to influenza vaccine in elderly subjects with low serum total protein or hemoglobin.
56-89-3 L-Cystine
SBP02717
Haplopine
Haplopine shows photo-activated antimicrobial activity against S. aureus. It exhibits potent melanogenesis-inhibitory activities with almost no toxicity to the cells. Haplopine is an organic heterotricyclic compound, an organonitrogen heterocyclic compound and an oxacycle.
5876-17-5 98% Haplopine
BP5005 107347-56-8 98% Tenacissoside E
BP3677
Isoformononetin
Isoformononetin shows fungitoxic activity against Cladosporium sphaerospermum; it also has immunomodulatory activity, it inhibits the differentiation of Th17 cells and B-cell lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions. Isoformononetin reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis. Isoformononetin is a methoxyisoflavone that is isoflavone substituted at positions 4' and 7 by hydroxy and methoxy groups respectively. It has a role as a metabolite, a bone density conservation agent and an apoptosis inhibitor. It is a member of 7-methoxyisoflavones and a hydroxyisoflavone. It is functionally related to a daidzein.
486-63-5 98% Isoformononetin
SBP03456 56-81-5 Glycerol
BPF2545
Alisol C
Alisol C can improve glucose uptake in Hep G2 cells, it may be one of the therapeutic material basis in hypoglycemic activities in A. orientalis. Alisol C,16,23-oxido-alisol B and alisol O in Zexie may cause nephrotoxicity.
30489-27-1 98% Alisol C
BP5321
Sibiricose A1
The sibiricosee A1, the sibiricose A5 and the tenuifoliside A have a better treatment function for tristimania caused by various reasons the sibiricose A5 and the tenuifoliside A have a certain protecting function for PC 12 cells damaged by glutamic acid and the sibiricosee A1, the sibiricose A5 and the tenuifoliside A all can shorten the tail-hanging resting time and the swim resting time of a mouse.
139726-40-2 98% Sibiricose A1
SBP03074 99633-05-3 14-Benzoylneoline
SBP02831 61617-29-6 Songoroside A
BP3008 111187-15-6 1,2-O-Dilinoleoyl-3-O-beta-D-galactopyranosylracglycerol
SBP02630 85769-33-1 Alstolenine
BP0635
Genistin
Supplementation of Genistin alone or with selenium provides antioxidant defense with high-potential chemopreventive activity against DMBA-induced mammary tumors more than selenium alone.Intravitreal injection of Genistin is safe and effective in reducing traumatic PVR in clinical treatment. Genistein 7-O-beta-D-glucoside is a 7-hydroxyisoflavones 7-O-beta-D-glucoside. It has a role as an anti-inflammatory agent, an apoptosis inducer and a cardioprotective agent. It is functionally related to a genistein. It is a conjugate acid of a genistein 7-O-beta-D-glucoside(1-).
529-59-9 98% Genistin
SBP02711 124096-81-7 16-Epikoumidine
BP0240
Bavachinin
Bavachinin is a novel natural pan-PPAR agonist , it shows stronger activities with PPAR-γ than with PPAR-α and PPAR-β/δ (EC50 = 0.74 μmol/l, 4.00 μmol/l and 8.07 μmol/l in 293T cells, respectively). Bavachinin possesses anti-asthma, anti-angiogenic , anti-inflammatory, antipyretic and analgesic properties, it also exhibits glucose-lowering properties without inducing weight gain and hepatotoxicity.
19879-30-2 98% Bavachinin
BP1430
Vanillic acid
Vanillic acid is a flavoring agent which has hepatoprotective, free radical scavenging, antioxidant and anti-inflammatory properties. It exerts protective effects in isoproterenol induced cardiotoxic rats, has inhibitory effect on methylglyoxal-mediated glycation in apoptotic Neuro-2A cells via inhibition of glycation mechanisms including ROS, p38 and JNK, PKC and p47(phox). Vanillic acid is a monohydroxybenzoic acid that is 4-hydroxybenzoic acid substituted by a methoxy group at position 3. It has a role as a plant metabolite. It is a methoxybenzoic acid and a monohydroxybenzoic acid. It is a conjugate acid of a vanillate.
121-34-6 98% Vanillic acid
BPF7962 75679-58-2 2',4'-Dihydroxy-4,6'-diMethoxydihydrochalcone
BP0090 28649-60-7 6,17-Epoxylathyrol
SBP00165 177602-14-1 Glycerol 1-(26-hydroxyhexacosanoate)